Modulation of Fc receptor mediated functions by split products of C3.

[1]  M. Dierich,et al.  C3 Cleaved by Membrane Proteases Binds to C3b Acceptors Expressed on Concanavalin A‐Stimulated Human Lymphocytes and Enhances Antibody‐Dependent Cellular Cytotoxicity , 1984, Scandinavian journal of immunology.

[2]  G. Füst,et al.  C3b acceptors on human peripheral blood mononuclear cells; characterization and functional role. , 1983, Immunology.

[3]  J. Gergely,et al.  C3b acceptors on macrophages: inhibition of Fc gamma-receptor-mediated phagocytosis by acceptor-bound C3b. , 1983, Immunology letters.

[4]  T. Schulz,et al.  Binding of the third component of complement (C3) to Thy-1.2 positive Con-A-induced blasts of the murine spleen: modulation of the C3 binding and cell aggregation by protease inhibitors. , 1983, Immunology.

[5]  G. Sármay,et al.  The Fc receptor model of membrane cytoplasmic signalling. , 1982, Molecular immunology.

[6]  F. Rosen,et al.  The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway. , 1981, Journal of Immunology.

[7]  G. Füst,et al.  Complement-dependent inhibition of Fc receptors on human peripheral blood mononuclear cells: inhibition of the binding of aggregated IgG, soluble and particulate immune complexes , 1980 .

[8]  H. Müller-Eberhard,et al.  Potentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b. , 1979, Journal of immunology.

[9]  W. Fries,et al.  Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro. , 1978, Immunology.

[10]  G. Sármay,et al.  Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes. , 1977, Clinical immunology and immunopathology.

[11]  J. Prahl,et al.  Third component of human complement: purification from plasma and physicochemical characterization. , 1976, Biochemistry.

[12]  G. Sármay,et al.  Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes. , 1976, Clinical immunology and immunopathology.